Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Vial

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cytometry. Part B, Clinical Cytometry|April 25, 2015
The routine leukocyte differential flow cytometry HematoFlow™ method: A new flagging system for automatic validationKaoutar Allou, Jean-Philippe Vial, Marie C Béné, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 3, 2019
An R-Derived FlowSOM Process to Analyze Unsupervised Clustering of Normal and Malignant Human Bone Marrow Classical Flow Cytometry DataFrancis Lacombe, Nicolas Lechevalier, Jean Philippe Vial, et al.
Annales De Biologie Clinique|October 7, 2016
Verification of a quantitative method: complete blood count by flow cytometry, the HematoFlow<sup>TM</sup> system (Beckman Coulter)Inès Vergnolle, Kaoutar Allou, Francis Lacombe, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 3, 2025
Low Dimensional Representation of Multi-Patient Flow Cytometry Datasets Using Optimal Transport for Measurable Residual Disease Detection in LeukemiaErell Gachon, Jérémie Bigot, Elsa Cazelles, et al.
Cancer Genetics and Cytogenetics|January 29, 2003
Derivative (7)t(7;8)(q34;q21). a new additional cytogenetic abnormality in acute promyelocytic leukemiaJean Philippe Vial, François Xavier Mahon, Arnaud Pigneux, et al.
Hemasphere|November 15, 2019
Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib EfficiencyKelly Airiau, Béatrice Turcq, Stéphane Bouchet, et al.
Cancers|February 10, 2021
Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid LeukemiaJean Philippe Vial, Nicolas Lechevalier, Francis Lacombe, et al.
Annales De Biologie Clinique|October 21, 2023
Principal component analysis yields results comparable to those of an elaborate Boolean strategy: simplifying the assessment of measurable residual disease in chronic lymphocytic leukemia patientsVictor-Emmanuel Brett, Marie-Sarah Dilhuydy, Nicolas Lechevalier, et al.
Acta Dermato-Venereologica|June 27, 2022
A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with ErythrodermaCamille Luherne, Sarah Menguy, Thomas Ferte, et al.
Annales De Biologie Clinique|June 24, 2021
[Use of the multiparametric panel CD3/CD4/CD8/CD7/CD26/CD158k in the detection and use of flow cytometry of Sezary cells]Jonas Callet, Véronique Latger-Cannard, Delphine Gérard, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cytometry. Part B, Clinical Cytometry|April 25, 2015
The routine leukocyte differential flow cytometry HematoFlow™ method: A new flagging system for automatic validationKaoutar Allou, Jean-Philippe Vial, Marie C Béné, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 3, 2019
An R-Derived FlowSOM Process to Analyze Unsupervised Clustering of Normal and Malignant Human Bone Marrow Classical Flow Cytometry DataFrancis Lacombe, Nicolas Lechevalier, Jean Philippe Vial, et al.
Annales De Biologie Clinique|October 7, 2016
Verification of a quantitative method: complete blood count by flow cytometry, the HematoFlow<sup>TM</sup> system (Beckman Coulter)Inès Vergnolle, Kaoutar Allou, Francis Lacombe, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 3, 2025
Low Dimensional Representation of Multi-Patient Flow Cytometry Datasets Using Optimal Transport for Measurable Residual Disease Detection in LeukemiaErell Gachon, Jérémie Bigot, Elsa Cazelles, et al.
Cancer Genetics and Cytogenetics|January 29, 2003
Derivative (7)t(7;8)(q34;q21). a new additional cytogenetic abnormality in acute promyelocytic leukemiaJean Philippe Vial, François Xavier Mahon, Arnaud Pigneux, et al.
Hemasphere|November 15, 2019
Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib EfficiencyKelly Airiau, Béatrice Turcq, Stéphane Bouchet, et al.
Cancers|February 10, 2021
Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid LeukemiaJean Philippe Vial, Nicolas Lechevalier, Francis Lacombe, et al.
Annales De Biologie Clinique|October 21, 2023
Principal component analysis yields results comparable to those of an elaborate Boolean strategy: simplifying the assessment of measurable residual disease in chronic lymphocytic leukemia patientsVictor-Emmanuel Brett, Marie-Sarah Dilhuydy, Nicolas Lechevalier, et al.
Acta Dermato-Venereologica|June 27, 2022
A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with ErythrodermaCamille Luherne, Sarah Menguy, Thomas Ferte, et al.
Annales De Biologie Clinique|June 24, 2021
[Use of the multiparametric panel CD3/CD4/CD8/CD7/CD26/CD158k in the detection and use of flow cytometry of Sezary cells]Jonas Callet, Véronique Latger-Cannard, Delphine Gérard, et al.
Pageof 3